Arrival, registration, media transfer at registration counter
“get together” snacks

Opening remarks
G-R Burmester, Andreas Radbruch

From Pathomechanisms to Cellular Targets
Chair: J.R. Kalden, Erlangen and G.-R. Burmester, Berlin

Marcel van den Brink, New York
Off-the-shelf adoptive cell therapy with T cell precursors across
MHC barriers

Rick Holmdahl, Stockholm
Therapeutic possibilities interacting with arthritogenic antibodies

Steffen Gay, Zürich                                     
Epigenetics in Rheumatic Diseases

Bruno Kyewski, Heidelberg
How central is central tolerance?

3:55 pm

Coffee break

Tobias Bopp, Mainz
Mechanisms of nTreg-mediated suppression

Christian Jorgensen, Montpellier
Genetic biomarkers for selected biotherapies in RA

B cells and Plasma Cells
Chair: Günter Steiner, Wien and Falk Hiepe, Berlin

Dinner-Buffet

Proinflammatory T cells
Chair: Rene van Lier, Amsterdam and Andreas Radbruch, Berlin

Francesco Annunziato, Florence
Human IL-17-producing cells: origin and development

Pierre Miossec, France
IL-17 and Th17: contribution to arthritis chronicity

Hyun-Dong Chang, Berlin
The pro-inflammatory immunological memory

Ken Smith, Cambridge
A CD8 T cell transcription signature predicts prognosis in autoimmune disease

Regulatory T cells
Chairs: Reinhold Schmidt, Hannover and Wlodzimierz Maslinski, Warsaw

Alf Hamann, Berlin
Stability and Epigenetic of Tregs

Berent Prakken, Utrecht
Regulatory T cells in autoimmunity: good guys, bad guys, or incompetent bystanders?

Hans Koenen, Nijmegen
Human regulatory T cell expansion, antigenspecificity and plasticity; lessons learned from allo-antigens

MSC, NK-cells & other cells
Chair: Thomas Pap, Münster and Ulf Müller-Ladner, Gießen

Francesco Dazzi, London
Mesenchymal stem cells and autoimmune disease – part I                  - the molecular basis for immunosuppression

Lorenzo Moretta, Genoa
Alloreactive NK cells in the therapy of high risk leukemias

Lessons from Clinical Stem Cell Reconstitutions
Chair: Dominique Farge, Paris and Ina Kötter, Tübingen

Riccardo Saccardi, Florence
Haematopoietic stem cell transplantation in autoimmune diseases:
The EBMT Experience

Dominique Farge, Paris
Long term results of hematopoietic stem cell transplantation: 1996-2008

Renate Arnold, Berlin
Haematopoietic Stem Cell Transplantation in SLE

Wietse Kuis, Utrecht
The role of stemcell transplantation and mesenchymal stemcells in pediatric rheumatology

Jaap van Laar, UK                                                                  
Risks and benefits of stem cell transplants, lessons learned in systemic sclerosis

Novel Concepts of Cell-Based Therapies
Chair: Dietger Niederwieser, Leipzig and Hans-Dieter Volk, Berlin

Alexander Scheffold, Bergisch-Gladbach  
Self-limitation of proinflammatory T cells as therapeutic strategy

Alan Tyndall, Basel  
Mesenchymal stem cells and autoimmune disease – part II                 - animal models and translational programs

Petra Reinke, Berlin
Adoptive T cell therapy - chance and challenges

Hans-Dieter Volk, Berlin
Crosstalk between stem cells and immune cells                       

Birgit Sawitzki, Berlin
Transfer of alloantigen specific Tregs to prevent rejection of allogeneic Transplants

European Perspectives
Chair: Andreas Radbruch, Berlin and Ulf Wagner, Leipzig